Literature DB >> 29045744

Developmental Differences Between Schizophrenia and Bipolar Disorder.

Mara Parellada1,2, Sandra Gomez-Vallejo1, Monica Burdeus1, Celso Arango1,2.   

Abstract

Ample evidence supports a neurodevelopmental origin in some cases of schizophrenia (SZ). More inconsistent information is available for bipolar disorder (BD). We herein review studies with a focus on premorbid (adjustment and functionality) and early developmental milestones that include both SZ and BD patients. A search was performed in the PubMed electronic database, retrieving 619 abstracts; 30 were ultimately included in this systematic review. Eight prospective cohorts, 15 retrospective studies, and 7 studies based on national registries. Psychomotor developmental deviations and general adjustment problems characterize the childhood of subjects later diagnosed with SZ or BD; they are more marked in those later diagnosed with SZ vs BD, earlier onset vs later onset, and psychotic vs nonpsychotic disorders. Cognitive impairment follows a linear risk trend for SZ and a U-shaped trend for BD. Social isolation and visuoperceptual/reading anomalies more frequently antecede SZ. Pervasive developmental disorders increase the risk for both SZ and BD, more so in cases with normal intelligence. The predictive risk of each isolated developmental marker is low, but a significant percentage of subjects with SZ and a minority of adults with BD showed signs of premorbid abnormalities in childhood. The great limitation is still the lack of studies comparing SZ and BD that include psychotic and nonpsychotic bipolar cases separately. There are many cases, even in childhood/adolescent SZ, where no premorbid anomalies are found, and immunological disorders or other etiologies should be searched for. At least in cases with clear neurodevelopmental markers, rare genetic variants should be investigated.
© The Author 2017. Published by Oxford University Press on behalf of the Maryland Psychiatric Research Center. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  cognition; neurodevelopment; prediction; premorbid; psychosis

Mesh:

Year:  2017        PMID: 29045744      PMCID: PMC5737496          DOI: 10.1093/schbul/sbx126

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  63 in total

1.  The dynamics of subthreshold psychopathology: implications for diagnosis and treatment.

Authors:  Jim van Os
Journal:  Am J Psychiatry       Date:  2013-07       Impact factor: 18.112

2.  The DSM-5: Classification and criteria changes.

Authors:  Darrel A Regier; Emily A Kuhl; David J Kupfer
Journal:  World Psychiatry       Date:  2013-06       Impact factor: 49.548

3.  Evidence for early-childhood, pan-developmental impairment specific to schizophreniform disorder: results from a longitudinal birth cohort.

Authors:  Mary Cannon; Avshalom Caspi; Terrie E Moffitt; HonaLee Harrington; Alan Taylor; Robin M Murray; Richie Poulton
Journal:  Arch Gen Psychiatry       Date:  2002-05

4.  Developmental precursors of affective illness in a general population birth cohort.

Authors:  J van Os; P Jones; G Lewis; M Wadsworth; R Murray
Journal:  Arch Gen Psychiatry       Date:  1997-07

5.  Demographics, family history, premorbid functioning, developmental characteristics, and course of patients with deteriorated affective disorder.

Authors:  C Vocisano; D N Klein; R S Keefe; E R Dienst; M M Kincaid
Journal:  Am J Psychiatry       Date:  1996-02       Impact factor: 18.112

6.  Differential neurodevelopmental trajectories in patients with early-onset bipolar and schizophrenia disorders.

Authors:  Celso Arango; David Fraguas; Mara Parellada
Journal:  Schizophr Bull       Date:  2013-12-26       Impact factor: 9.306

7.  Neuropsychological performance and family history in children at age 7 who develop adult schizophrenia or bipolar psychosis in the New England Family Studies.

Authors:  L J Seidman; S Cherkerzian; J M Goldstein; J Agnew-Blais; M T Tsuang; S L Buka
Journal:  Psychol Med       Date:  2012-05-11       Impact factor: 7.723

8.  Cognitive function in childhood and early adulthood and hospital admission for schizophrenia and bipolar disorders in Danish men born in 1953.

Authors:  Merete Osler; Debbie A Lawlor; Merete Nordentoft
Journal:  Schizophr Res       Date:  2007-03-06       Impact factor: 4.939

9.  Preceding diagnoses to young adult bipolar disorder and schizophrenia in a nationwide study.

Authors:  Søren Martin Andersen; Anne Randers; Christina Mohr Jensen; Charlotte Bisgaard; Hans-Christoph Steinhausen
Journal:  BMC Psychiatry       Date:  2013-12-21       Impact factor: 3.630

10.  "To see or not to see: that is the question." The "Protection-Against-Schizophrenia" (PaSZ) model: evidence from congenital blindness and visuo-cognitive aberrations.

Authors:  Steffen Landgraf; Michael Osterheider
Journal:  Front Psychol       Date:  2013-07-01
View more
  30 in total

1.  Neuropsychological functioning in early and chronic stages of schizophrenia and psychotic bipolar disorder.

Authors:  Margo W Menkes; Kristan Armstrong; Jennifer Urbano Blackford; Stephan Heckers; Neil D Woodward
Journal:  Schizophr Res       Date:  2018-10-26       Impact factor: 4.939

2.  Developmental Interactive Framework for Psychotic Disorders.

Authors:  William T Carpenter; John S Strauss
Journal:  Schizophr Bull       Date:  2017-10-21       Impact factor: 9.306

3.  Studying Developmental Psychopathology Related to Psychotic Disorders-Challenges and Paradigms in Human Studies.

Authors:  Andreas Meyer-Lindenberg
Journal:  Schizophr Bull       Date:  2017-10-21       Impact factor: 9.306

4.  Differences in the regulation of inflammatory pathways in adolescent- and adult-onset first-episode psychosis.

Authors:  C Moreno; M Parellada; K S MacDowell; B García-Bueno; B Cabrera; A González-Pinto; P Saiz; A Lobo; R Rodriguez-Jimenez; E Berrocoso; M Bernardo; J C Leza
Journal:  Eur Child Adolesc Psychiatry       Date:  2019-03-06       Impact factor: 4.785

5.  Assessment of the Prodromal Questionnaire-Brief Child Version for Measurement of Self-reported Psychoticlike Experiences in Childhood.

Authors:  Nicole R Karcher; Deanna M Barch; Shelli Avenevoli; Mark Savill; Rebekah S Huber; Tony J Simon; Ingrid N Leckliter; Kenneth J Sher; Rachel L Loewy
Journal:  JAMA Psychiatry       Date:  2018-08-01       Impact factor: 21.596

6.  Future of Days Past: Neurodevelopment and Schizophrenia.

Authors:  Daniel R Weinberger
Journal:  Schizophr Bull       Date:  2017-10-21       Impact factor: 9.306

Review 7.  Cognitive Deficits in Psychotic Disorders: A Lifespan Perspective.

Authors:  Julia M Sheffield; Nicole R Karcher; Deanna M Barch
Journal:  Neuropsychol Rev       Date:  2018-10-20       Impact factor: 7.444

8.  Contributions of childhood trauma and atypical development to increased clinical symptoms and poor functioning in recent onset psychosis.

Authors:  Adi Rosenthal; Monet S Meyer; Danessa Mayo; Laura M Tully; Pooja Patel; Stefania Ashby; Madison Titone; Cameron S Carter; Tara A Niendam
Journal:  Early Interv Psychiatry       Date:  2020-02-10       Impact factor: 2.732

9.  Demographic and Clinical Characteristics, Including Subsyndromal Symptoms Across Bipolar-Spectrum Disorders in Adolescents.

Authors:  Gonzalo Salazar de Pablo; Daniel Guinart; Barbara A Cornblatt; Andrea M Auther; Ricardo E Carrión; Maren Carbon; Sara Jiménez-Fernández; Ditte L Vernal; Susanne Walitza; Miriam Gerstenberg; Riccardo Saba; Nella Lo Cascio; Martina Brandizzi; Celso Arango; Carmen Moreno; Anna Van Meter; Christoph U Correll
Journal:  J Child Adolesc Psychopharmacol       Date:  2020-02-21       Impact factor: 2.576

10.  Genetic underpinnings of sociability in the general population.

Authors:  Janita Bralten; Nina R Mota; Barbara Franke; Geert Poelmans; Cornelius J H M Klemann; Ward De Witte; Emma Laing; David A Collier; Hilde de Kluiver; Stephanie E E C Bauduin; Celso Arango; Jose L Ayuso-Mateos; Chiara Fabbri; Martien J Kas; Nic van der Wee; Brenda W J H Penninx; Alessandro Serretti
Journal:  Neuropsychopharmacology       Date:  2021-05-30       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.